9
report
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief
The Milken Institute Center for Public Health and FasterCures have identified three PAHPA 2023 poli
cy priorities that are core to improving and strengthening the nation’s biosecurity and preparedness infrastructure.
+ Read More
article
Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561
Lauren K. Roth
Associate Commissioner for Policy
Food and Drug Administration
5630 Fishers Lane, Rm.
1061
Rockville, MD 20852
Dear Ms. Roth,
+ Read More
article
The 2024-2025 FasterCures LeadersLink Cohort
The 2024–2025 FasterCures’ LeadersLink program cohort has been carefully selected from a highly comp
etitive pool of candidates.
+ Read More
article
TRAIN Newsletter — April 2024
TRAIN eNews is delivered directly to organizations participating in The Research Acceleration and In
novation Network (TRAIN).
+ Read More
article
FasterCures Quarterly Update—April 2024
In This Newsletter
New FasterCures Team Member
Policy Updates
Events and Convenings Recap
FasterCur
es in the Community
+ Read More
article
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
Submitted electronically
Dr. Robert Califf
Commissioner
US Food and Drug Administration
Silver Spri
ng, MD 20993
Dear Dr. Califf,
+ Read More
article
FasterCures Quarterly Update: July 2023
In This Issue:
Convenings Recap
Policy Updates
FasterCures in the Media
FasterCures in the Communit
y
+ Read More
video
Building Impactful, Transparent, and Reciprocal Relationships with Industry Partners
How can patient organizations hoping to leverage the resources of industry researchers attract the
ir support and establish formal industry partnerships?
+ Read More